fig2
Figure 2. Translational workflow from ncRNA discovery to clinical use. Public resources such as miRBase, LNCipedia, and circBase support annotation and discovery; biofluid profiling and biomarker validation refine candidate selection; and delivery platforms such as lipid nanoparticles, exosomes, and antisense oligonucleotides enable therapeutic translation. LNPs: Lipid nanoparticles; ASOs: antisense oligonucleotides.
